This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Jun;1(5):904-9.

doi: 10.1016/0952-7915(89)90069-1.

Analysis of effector mechanisms in cancer

E Lotzová¹

Affiliations

PMID: 2679738
DOI: 10.1016/0952-7915(89)90069-1

Review

Analysis of effector mechanisms in cancer

E Lotzová. Curr Opin Immunol. 1989 Jun.

. 1989 Jun;1(5):904-9.

doi: 10.1016/0952-7915(89)90069-1.

Author

E Lotzová¹

Affiliation

¹ Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston.

PMID: 2679738
DOI: 10.1016/0952-7915(89)90069-1

No abstract available

PubMed Disclaimer

Similar articles

Interleukin-2, killer cells and cancer therapy: an overview.
Parkinson DR, Lotzová E. Parkinson DR, et al. Nat Immun Cell Growth Regul. 1990;9(4):237-41. Nat Immun Cell Growth Regul. 1990. PMID: 2215512 Review. No abstract available.
Natural killer cells, lymphokine-activated killer cells, and cytolytic T lymphocytes: compartmentalization of age-related changes in cytolytic lymphocytes?
Bloom ET. Bloom ET. J Gerontol. 1994 May;49(3):B85-92. doi: 10.1093/geronj/49.3.b85. J Gerontol. 1994. PMID: 8169331 Review. No abstract available.
[Identification and characterization of effector lymphocytes lysing autologous tumor cells].
Kumagai K, Fujii M, Abo T, Sawada H, Kato M, Itoh K, Satoh T. Kumagai K, et al. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-2):1462-8. Gan To Kagaku Ryoho. 1989. PMID: 2658829 Review. Japanese.
Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity.
Kumagai K, Takeda K, Hashimoto W, Seki S, Ogasawara K, Anzai R, Takahashi M, Sato M, Rikiishi H. Kumagai K, et al. Int Rev Immunol. 1997;14(2-3):229-56. doi: 10.3109/08830189709116854. Int Rev Immunol. 1997. PMID: 9131389 Review. No abstract available.
[Functional changes in lymphokine-activated lymphocytes depending on the incubation time with interleukin-2].
Sashchenko LP, Gnuchev NV, Kabanova OD, Blishchenko EIu, Luk'ianova TI, Redchenko IV, Savtsova ZD, Chertov OIu, Lukanidin EM. Sashchenko LP, et al. Dokl Akad Nauk. 1992;324(2):475-9. Dokl Akad Nauk. 1992. PMID: 1451639 Russian. No abstract available.

See all similar articles

Cited by

Induction of lymphokine-activated killer activity in mice by prothymosin alpha.
Baxevanis CN, Gritzapis AD, Dedoussis GV, Papadopoulos NG, Tsolas O, Papamichail M. Baxevanis CN, et al. Cancer Immunol Immunother. 1994 Apr;38(4):281-6. doi: 10.1007/BF01533521. Cancer Immunol Immunother. 1994. PMID: 8168124 Free PMC article.
High release of tumor necrosis factor alpha, interferon gamma and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells.
Koberda J, Bergmann L, Mitrou PS, Hoelzer D. Koberda J, et al. J Cancer Res Clin Oncol. 1991;117(5):425-30. doi: 10.1007/BF01612762. J Cancer Res Clin Oncol. 1991. PMID: 1909699 Free PMC article.
The expression and cellular distribution of adhesion molecules CD2/LFA-3 and ICAM-1/LFA-1 on mononuclear cells in squamous cell carcinoma of the head and neck.
Kornfehl J, Neuchrist C, Grasl MC, Ehrenberger K, Kraft D, Scheiner O. Kornfehl J, et al. Eur Arch Otorhinolaryngol. 1993;250(3):168-72. doi: 10.1007/BF00171705. Eur Arch Otorhinolaryngol. 1993. PMID: 7689328

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

CA 39632/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science